Cargando…
Diagnostic value of fractional exhaled nitric oxide for asthma-chronic obstructive pulmonary disease overlap syndrome
To examine the difference in the fractional exhaled nitric oxide (FeNO) between chronic obstructive pulmonary disease (COPD) patients with asthma-COPD overlap syndrome (ACOS) and patients with Non-ACOS COPD (Non-ACOS) and to investigate the correlation between FeNO levels and the differential cell c...
Autores principales: | Guo, Yuanyuan, Hong, Chunlin, Liu, Yanhong, Chen, Huinuan, Huang, Xiaohua, Hong, Minli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999511/ https://www.ncbi.nlm.nih.gov/pubmed/29879019 http://dx.doi.org/10.1097/MD.0000000000010857 |
Ejemplares similares
-
Fractional Exhaled Nitric Oxide Testing: Diagnostic Utility in Asthma, Chronic Obstructive Pulmonary Disease, or Asthma-chronic Obstructive Pulmonary Disease Overlap Syndrome
por: Miskoff, Jeffrey A, et al.
Publicado: (2019) -
Importance of fractional exhaled nitric oxide in the differentiation of asthma–COPD overlap syndrome, asthma, and COPD
por: Chen, Feng-jia, et al.
Publicado: (2016) -
Effects of the Chinese herb formula Yufeining on stable chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial
por: Hong, Minli, et al.
Publicado: (2018) -
Re-evaluation of the diagnostic value of fractional exhaled nitric oxide & its impact in patients with asthma
por: He, Lixiu, et al.
Publicado: (2018) -
Investigating fractional exhaled nitric oxide (FeNO) in chronic obstructive pulmonary disease (COPD) and asthma–COPD overlap (ACO): a scoping review protocol
por: Mostafavi-Pour-Manshadi, Seyed-Mohammad-Yousof, et al.
Publicado: (2017)